Lakeside Holding Ltd

Lakeside Holding Ltd is a U.S.-based cross-border supply chain and logistics company focused on moving goods from Asia into the United States. It combines ocean and air freight forwarding with customs clearance, warehousing, distribution, and domestic ground transport, and it has recently expanded into pharmaceutical distribution through its Hupan Pharmaceutical subsidiary in China.

94

2.03

0.67

— Lakeside Holding Ltd
%
Cross-border ocean freight solutions35% Ocean freight consolidation and forwarding services for goods shipped into the U.S. from Asia.
Cross-border airfreight solutions25% Airfreight forwarding and value-added handling for time-sensitive imports into the U.S.
Integrated logistics services25% Customs clearance, warehousing, distribution, and domestic ground transport tied to freight flows.
Pharmaceutical distribution15% Distribution of infusion fluids and other pharmaceutical/medical products sourced from manufacturers.

The core customer base consists of Asia- and U.S.-based logistics service companies that support e-commerce, social...

  • Cross-border logistics intermediariesprimary

    Logistics service companies that buy freight forwarding and consolidation to move Asian-origin cargo into the U.S.

  • E-commerce and social commerce supply chainsprimary

    Platform-linked shippers that need flexible ocean and air solutions plus handling services for imported goods.

  • Manufacturers and importerssecondary

    Producers shipping consumer and industrial goods into the U.S. that need customs and domestic transport support.

  • Healthcare buyers in Chinaemerging

    Distributors, hospitals, and clinics purchasing pharmaceutical products and infusion fluids.

The company is headquartered in the United States and was founded in Chicago, but its commercial focus is tied to Asia,...

  • Headquartered in the United States, founded in Chicago
  • Core logistics focus on Asian trade lanes into the U.S.
  • Strategic market emphasis on China and South Korea
  • Pharmaceutical segment headquartered in Wuhan, China
  • Operations span U.S. import handling and China healthcare distribution

Management is focused on expanding the customer base, improving service breadth, and using technology to support more...

01
Grow the cross-border customer baseshort-term

Revenue depends on recurring freight and logistics orders, so customer acquisition and retention are central.

02
Expand value-added logistics servicesmedium-term

Warehousing, repackaging, customs, and domestic transport can improve margins and differentiation.

03
Scale pharmaceutical distributionmedium-term

The new healthcare segment diversifies revenue but requires tighter compliance and working capital control.

The business is exposed to freight capacity, carrier reliability, customs regulation, and trade-policy changes because...

high

Carrier capacity and freight market volatility

The company relies on ocean and air carriers for consolidation and forwarding, so capacity shortages or pricing changes can affect service and margins.

Scope
Cross-border ocean and air freight
Materiality
high
high

Customs and trade regulation changes

Customs clearance is part of the service offering, and changes in trade accords, quotas, or brokerage rules can disrupt flows.

Scope
U.S.-Asia import lanes
Materiality
high
high

Pharmaceutical compliance and product quality

Medical product distribution requires stricter handling, storage, and regulatory compliance than freight forwarding.

Scope
Hupan Pharmaceutical segment
Materiality
high
medium

Working capital and liquidity pressure

Buying and holding pharmaceutical inventory increases cash tied up in operations and can strain liquidity.

Scope
Inventory-heavy distribution model
Materiality
medium
medium

Customer concentration and retention

Growth depends on expanding and maintaining a relatively small customer base in a service-intensive business.

Scope
Cross-border logistics and healthcare customers
Materiality
medium
Revenue recognition across logistics and pharmaceutical distribution
Can shift revenue between periods and affect gross margin comparability
Inventory accounting for pharmaceutical products
Affects gross profit, write-down risk, and working capital
Lease accounting
Influences reported liabilities, operating cash flow, and fixed-cost burden
Convertible notes and warrants
Can affect interest expense, equity classification, and EPS

: 28/04/2026